Masterclass Mondays: Session 2 - M&A


Morrison & Foerster
One Ropemaker Street
London   EC2Y 9AW
Lorna O'Neill
44 20 7920 4007

Morrison & Foerster and Alacrita Consulting invite you to join us for the second of two seminars looking at the areas of corporate interaction between biotechs and larger healthcare companies.

This masterclass series will consider current issues relevant to life sciences transactions and which distinguish deals in this sector from other sectors.

Guest speaker, Ian Garland (CEO of Vernalis, ex-Acambis, ex-Arrow) will give his insights into selling biotechs to larger healthcare companies.  Charles Spicer (Alacrita Consulting), an experienced corporate finance adviser, will air his views on market trends in life sciences M&A. Nuances of life sciences M&A deals will be discussed by Paul Claydon and James Halstead (Morrison & Foerster).  The seminar will conclude with a panel discussion to be chaired by Ed Lukins (Morrison & Foerster) to be followed by drinks and networking.


  • Ian Garland, CEO, Vernalis
  • Charles Spicer, Alacrita Consulting
  • Paul Claydon, Partner, Morrison & Foerster, London
  • James Halstead, Partner, Morrison & Foerster, London
  • Ed Lukins, Partner, Morrison & Foerster, London

Registration: 4.30 PM
Speakers: 5.00 PM - 6.30 PM
Panel discussion: 6.30 PM - 7.00 PM

Networking drinks to follow

This invitation is transferable and open to colleagues.  There is no charge to attend this seminar. 

Morrison & Foerster (UK) LLP (Authorisation Number 3538/MOFO) certifies that this activity has been approved for CPD credit by the Solicitors Regulation Authority for the amount of 2 hours.




Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.